The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.01BCNY
1.35B · vs all stocks (USD)
Updated Nov 19, 2026
Revenue (TTM)
53.68BCNY
8.05B · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
-0.71%
Updated Nov 19, 2026
Beta
0.5950x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-31.96%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
9.01BCNY
1.35B · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
21.85BCNY
3.28B · vs all stocks (USD)
Updated Nov 19, 2026
Forward P/E
15.04x
Updated Nov 19, 2026
Price to Sales (TTM)
0.1747x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.17×.Updated Nov 19, 2026
Price to Book (MRQ)
1.05x
Updated Nov 19, 2026
Enterprise to Revenue
0.4070x
Updated Nov 19, 2026
Enterprise to EBITDA
81.15x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 15.24×.Updated Nov 19, 2026
Gross Margin
5.65%
Updated Nov 19, 2026
Profit Margin
-0.71%
Updated Nov 19, 2026
Operating Margin
0.16%
Updated Nov 19, 2026
Return on Assets (TTM)
0.10%
Updated Nov 19, 2026
Return on Equity (TTM)
-4.24%
Updated Nov 19, 2026
Revenue (TTM)
53.68BCNY
8.05B · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
24.73CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
-20.80%
Updated Nov 19, 2026
Gross Profit (TTM)
2.39BCNY
358.77M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
1.43BCNY
215.08M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
-382.96MCNY
-57.44M · vs all stocks (USD)
Updated Nov 19, 2026
Quarterly Earnings Growth (YoY)
-44.22%
Updated Nov 19, 2026
Operating Cash Flow (TTM)
802.77MCNY
120.41M · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
339.95MCNY
50.99M · vs all stocks (USD)
Updated Nov 19, 2026
5-Year Average Dividend Yield
0.32%
vs all stocks
Updated Nov 19, 2026
Payout Ratio
33.33%
Updated Nov 19, 2026
Minority Interest (Equity)
1.11BCNYFY2025 · Dec 31, 2025
Revenue
68.19BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
65.27BCNYFY2025 · Dec 31, 2025
Gross Profit
2.92BCNYFY2025 · Dec 31, 2025
Operating Income
871.80MCNY
130.76M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-371.40MCNYFY2025 · Dec 31, 2025
Income Tax Expense
7.47MCNYFY2025 · Dec 31, 2025
Net Income
-378.87MCNYFY2025 · Dec 31, 2025
EBIT
645.03MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.43BCNYFY2025 · Dec 31, 2025
Research & Development
31.55MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
905.34MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
208.30MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
208.82MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.02BCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.66BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.66BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-378.87MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
59.78MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
1.03BCNYFY2025 · Dec 31, 2025
Free Cash Flow
738.13MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
2.81BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-378.87MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
882.42MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-299.69MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
828.89MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-294.63MCNYFY2025 · Dec 31, 2025
Net Acquisitions
410.70MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-122.70MCNYFY2025 · Dec 31, 2025
Sale of Investments
195.72MCNYFY2025 · Dec 31, 2025
Other Investing Activity
283.69MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
472.78MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
28.25BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-32.86BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.12BCNYFY2025 · Dec 31, 2025
Other Financing Charges
4.16BCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.58BCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.60BSharesUpdated Nov 19, 2026
Float Shares
1.75BSharesUpdated Nov 19, 2026
% Held by Insiders
26.99%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
8.71%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
9.99BCNY
1.50B · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
3.85CNYUpdated Nov 19, 2026
Total Debt (MRQ)
21.45BCNY
3.22B · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
2.15x
Updated Nov 19, 2026
Current Ratio (MRQ)
1.01x
Updated Nov 19, 2026
Book Value per Share (MRQ)
3.44CNYUpdated Nov 19, 2026
Total Assets
58.04BCNY
8.71B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
46.73BCNYFY2025 · Dec 31, 2025
Total Liabilities
47.82BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
11.31BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.29BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
45.52BCNYFY2025 · Dec 31, 2025
Cash
2.81BCNYFY2025 · Dec 31, 2025
Cash Equivalents
12.43BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
15.25BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
5.25MCNYFY2025 · Dec 31, 2025
Accounts Receivable
16.54BCNYFY2025 · Dec 31, 2025
Inventory
6.25BCNYFY2025 · Dec 31, 2025
Accounts Payable
22.44BCNYFY2025 · Dec 31, 2025
Short-term Debt
19.84BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
229.27MCNYFY2025 · Dec 31, 2025
Long-term Debt
2.00BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
12.10MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.60BCNYFY2025 · Dec 31, 2025
Retained Earnings
2.13BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
10.22BCNY
1.53B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
3.44CNYUpdated Nov 19, 2026
52-Week High
7.93CNYUpdated Nov 19, 2026
52-Week Change
-31.96%
vs all stocks
Updated Nov 19, 2026
Beta
0.5950x
vs all stocks
Updated Nov 19, 2026
50-Day MA
4.10CNYUpdated Nov 19, 2026
200-Day MA
5.06CNYUpdated Nov 19, 2026
Avg 10-Day Volume
33.33MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
39.17MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
-0.1400CNYUpdated Nov 19, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.4: grey zoneSignificant
Altman Z-Score: 1.40
Low earnings qualitySignificant
Earnings Quality Score: -2.16
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Scale
Market cap is $1.35B, above the global median of $1.14BNotable
Market cap (USD): 1,351,653,115.535Global Median: 1,137,180,293.291
Revenue is $8.05B, above the global median of $566.17MNotable